Stay updated on Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The date has been updated from May 23, 2025, to June 26, 2025.
    Difference
    0.6%
    Check dated 2025-06-27T00:34:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-19T19:37:38.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:12:57.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation.
    Difference
    7%
    Check dated 2025-05-29T05:57:13.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:56:46.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The date has been updated from February 25, 2025, to April 18, 2025.
    Difference
    0.7%
    Check dated 2025-04-23T08:36:04.000Z thumbnail image

Stay in the know with updates to Pediatric Galcanezumab for Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Galcanezumab for Episodic Migraine Clinical Trial page.